Bristol Myers to buy Cambridge startup Orbital Therapeutics, building out cell therapy pipeline – The Boston Globe
Bristol Myers Squibb said Friday that it would buy Cambridge startup Orbital Therapeutics for $1.5 billion in cash, the latest…
Bristol Myers Squibb said Friday that it would buy Cambridge startup Orbital Therapeutics for $1.5 billion in cash, the latest…
Bristol-based Wanda Health, an intelligent platform for Remote Patient Monitoring (RPM) and Virtual Care, has successfully closed an investment round…
Siloton, the Bristol-based health technology startup, has trialled its Akepa device – a first-generation optical coherence tomography (OCT) chip –…